Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Illumina

Premium
Affymetrix this week launched its GeneChip HT Array Plate System, a microarray processing platform that analyzes up to 96 samples at a time. The Array Plate System is designed for larger-scale studies and targets large pharmaceutical companies and clinical research laboratories.
 
The system uses Affy’s GeneChip HT Array Plates, which cover the transcribed human, mouse, and rat genomes in a format that enables researchers to interrogate either 24 or 96 distinct samples at one time. Also included with the system are the GeneChip Array Station for automated target preparation, the GeneChip HT Array Plate Scanner, and GeneChip HT Software Suite.
 

 
Illumina last week launched its BeadXpress System. The platform uses Illumina's VeraCode digital microbead technology, and offers high-quality data, broad multiplexing capability, and assay flexibility, the company said (see related story, this issue).
 
BeadXpress uses a two-color laser-detection capability and is suited for low- to mid-multiplex experiments. Key application areas include biomarker research and validation, pharmaceutical development, industrial testing, agriculture, clinical research, and the development of molecular diagnostic assays, Illumina said.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.